HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 281, Issue 11, 6964-6969, March 17, 2006

This Article Abstract Full Text (PDF) All Versions of this Article: 281/11/6964    most recent M513257200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, C. Articles by Mobashery, S. Search for Related Content PubMed PubMed Citation Articles by Kim, C. Articles by Mobashery, S. Social Bookmarking                      What's this?

Hydrolysis of ATP by Aminoglycoside 3'-Phosphotransferases

AN UNEXPECTED COST TO BACTERIA FOR HARBORING AN ANTIBIOTIC RESISTANCE ENZYME^*

Choonkeun Kim, Joo Young Cha, Honggao Yan, Sergei B. Vakulenko, and Shahriar Mobashery¹

From the Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556 and the Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan 48824

Received for publication, December 13, 2005

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

 
Aminoglycoside 3'-phosphotransferases (APH(3')s) are common bacterial resistance enzymes to aminoglycoside antibiotics. These enzymes transfer the -phosphoryl group of ATP to the 3'-hydroxyl of the antibiotics, whereby the biological activity of the drugs is lost. Pre-steady-state and steady-state kinetics with two of these enzymes from Gram-negative bacteria, APH(3')-Ia and APH(3')-IIa, were performed. It is demonstrated that these enzymes in both ternary and binary complexes facilitate an ATP hydrolase activity (ATPase), which is competitive with the transfer of phosphate to the antibiotics. Because these enzymes are expressed constitutively in resistant bacteria, the turnover of ATP is continuous during the lifetime of the organism both in the absence and the presence of aminoglycosides. Concentrations of the enzyme in vivo were determined, and it was estimated that in a single generation of bacterial growth there exists the potential that this activity would consume as much as severalfold of the total existing ATP. Studies with bacteria harboring the aph(3')-Ia gene revealed that bacteria are able to absorb the cost of this ATP turnover, as ATP is recycled. However, the cost burden of this adventitious activity manifests a selection pressure against maintenance of the plasmids that harbor the aph(3')-Ia gene, such that 50% of the plasmid is lost in 1500 bacterial generations in the absence of antibiotics. The implication is that, in the absence of selection, bacteria harboring an enzyme that catalyzes the consumption of key metabolites could experience the loss of the plasmid that encodes for the given enzyme.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

 
The most common mechanism for bacterial resistance to antibiotics is the acquisition of resistance genes. The enzymes encoded by these genes modify the structures of antibiotics, such that the modified drugs bind poorly to their targets. Among these antibiotic resistance enzymes, those for aminoglycoside antibiotics are widespread in pathogens (1–5). Of these enzymes, the aminoglycoside 3'-phosphotransferases (APH(3')s)² are the most common, and they are responsible for the demise of kanamycin, among other aminoglycosides, as a treatment option. The phosphorylation reaction of kanamycin A (structure 1) catalyzed by this enzyme is shown in Fig. 1. These enzymes are present in both Gram-negative and Gram-positive organisms.

Bacteria pay an initial price in the acquisition of antibiotic resistance determinants. The price is in the replication and maintenance of the additional genetic material in a naïve organism; that is, one previously not exposed to the given resistance gene (6, 7). It is believed that over many generations of growth, the resistant organism acquires additional compensatory mutations such that the cost of harboring the resistance gene diminishes and ultimately is eliminated. The implication is that the strains should be able to stably keep resistance genes in the absence of selective pressure with antibiotics (8–11).

Whereas the bona fide function of APH(3')s is the transfer of the -phosphoryl group of ATP to the aminoglycoside antibiotics, we observed that APH(3')s from Gram-negative bacteria also catalyze hydrolysis of ATP (12, 13). At the time we deemed this reaction as insignificant, believing the transfer of the -phosphoryl group of ATP to the aminoglycosides as considerably more favorable. That these enzymes were capable of ATP hydrolysis was not a surprising finding, as the enzyme binds MgATP for the purpose of facilitating -phosphoryl transfer as its normal function. This phosphoryl group is merely being transferred to a water molecule in the ATPase activity. The pre-steady-state kinetics for transfer of the -phosphoryl group of ATP to kanamycin, neamine, and water, investigated in this report, proved surprising. We disclose that the cost of this ATPase activity is seemingly significant, but at first glance at the phenotypic level, the organisms appear to absorb this cost. However, in the absence of selection, bacteria harboring APH(3')s experience the loss of the plasmid that encodes for the enzyme. It would appear that these resistance enzymes place an additional burden on the bacterial host above and beyond the standard replicational burden. This goes counter to the aforementioned concept on stable retention of the resistance determinants in the long run, at least for the case of APH(3')s (8–11).

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

 
Plasmid Construction—To construct plasmid pUC-APH, the aph(3')-Ia gene was excised from plasmid pUC4K (Amersham Biosciences) with BamHI endonuclease and inserted into the BamHI site of plasmid pUC19. Then, the bla_TEM-1 gene encoding TEM-1 -lactamase was removed from the construct by digestion with restriction endonucleases AatII and DraI and religation. Plasmid pUC-TEM was constructed by substituting the aph(3')-Ia gene in the plasmid pUC-APH with the bla_TEM-1 gene from the plasmid pUC19. This was performed by PCR-amplification of the pUC-APH plasmid with primers, PUC-S (5'-AACACCCCTTGTATTACTGTTTATG-3') and PUC-E (5'-CTGGCAGATCTTTACGCTGACTTGACGGGA-3'; BglII site underlined) that would amplify the entire plasmid except for the aph(3')-Ia gene. The bla_TEM-1 gene was subsequently amplified from the plasmid pUC19 with two primers TEM-S (5'-ATGAGTATTCAACATTTCCGTGTCG-3') and TEM-E (5'-AAACTAGATCTGACAGTTACCAATGCTTAA-3'; BglII site underlined). PCR products were digested with the BglII, gel-purified, and ligated to produce plasmid pUC-TEM. Plasmids pACYC-APH and pACYC-TEM were prepared in a similar way. The plasmid pACYC-APH containing only the aph(3')-Ia gene was constructed by removing the bla_TEM-1 gene with endonucleases AatII and DraI from the commercial plasmid pACYC177 harboring both the aph(3')-Ia and bla_TEM-1 genes (New England BioLabs, Beverly, MA). The plasmid pACYC-TEM was completed by the ligation of two PCR-generated fragments. The first fragment was produced by PCR-amplification of the plasmid pACYC-APH with the following oligonucleotide primers, PACYC-S (5'-AACACCCCTTGTATTACTGTTTATG-3') and PACYC-E (5'-GGCAGATCTTTACGCTGACTTGACGGGACG-3'; BglII site underlined). The second fragment was the same PCR-amplified bla_TEM-1 gene that was used to construct the plasmid pUC-TEM (see above). The sequences of all constructs were confirmed by DNA sequencing. In all constructs both the bla_TEM-1 and the aph(3')-Ia genes were controlled by the same aph(3')-Ia gene promoter.

Plasmid pACYCD216W, which harbors the gene for the D216W mutant variant of APH(3')-Ia, was generated by site-directed mutagenesis. The plasmid pUC-APH was amplified by Pfu Turbo DNA polymerase and two mutagenic primers, D216WD (5'-GGAAATTAATAGGTTGTATTTGGGTTGGACGAGTCGGAATCG-3'; mutation site underlined) and D216WR (5'-CGATTCCGACTCGTCCAACCCAAATACAACCTATTAATTTCC-3'; mutation site underlined). The PCR products were cleaned with the gel extraction kit (Qiagen) and treated with restriction enzyme DpnI to remove methylated template plasmids. The amplified plasmids were then transformed into Escherichia coli JM83. The nucleotide sequence was verified for the entire gene. The mutated plasmid, pUC-mAPH, was digested with BamHI and HindIII. The fragment containing the mutation site was ligated into the corresponding site of pACYC177, and the product of ligation (pACYCD216W) was used to transform E. coli K-12.

Determination of the Concentration of APH(3')-Ia in Vivo—Using the following parameters: cell length (L), 2 µm; cell diameter (D), 0.8 µm; outer membrane thickness (O), 10 nm; inner membrane thickness (I), 8 nm; periplasm thickness (P), 10 nm; nuclear volume (N), 0.16 x 10^–15 L, we first calculated that the cytoplasmic volume (C) for a single E. coli cell at 0.67 x 10^–15 L. Calculations were made according to Equation 1 (15, 16).³

(Eq. 1)

Subsequently, we determined the in vivo concentration of APH(3')-Ia produced from the pACYC-APH and pUC-APH plasmids in E. coli K-12 cells using SDS-PAGE and ImageQuant 5.2 software from Amersham Biosciences. E. coli K-12 strain carrying no plasmids was used as a negative control. Strains were grown until the A₆₀₀ of 0.2. One milliliter of each strain was centrifuged at 10,000 x g for 30 s. The pellets were resuspended in 1 ml of washing buffer (50 mM HEPES, pH 7.5 and 1 mM EDTA) and 150 µl of each was used for protein separation on a 12% SDS-PAGE; several concentrations of purified APH(3')-Ia were used as standards (0.6, 1.2, 3.1, 6.2, and 12.5 µg/lane). Proteins were stained with Coomassie Blue and scanned, and the amount of the APH(3')-Ia was quantified by using the ImageQuant 5.2 program. The quantity of APH(3')-Ia from E. coli K-12 strains producing APH(3')-Ia was calculated by subtracting the band corresponding to the small amount of protein of E. coli K-12 strain not harboring any plasmid from that of corresponding location in the gel for APH(3')-Ia from the same organism harboring plasmid pACYC-APH or pUC-APH. Simultaneously, several dilutions of cultures were made, and cells were plated onto LB (Luria-Bertani) agar plates to count numbers of cells in 150 µl of each culture. Concentration of APH(3')-Ia in vivo was evaluated by dividing the amount of APH(3')-Ia in 150 µl of cell culture by both the number of cells in 150 µl and by the cytoplasmic volume of a single E. coli cell.

View larger version (11K): [in this window] [in a new window]   FIGURE 1. The reaction of APH(3')s. These enzymes catalyze the transfer of the -phosphoryl group of ATP to the 3'-hydroxyl of aminoglycoside antibiotics (kanamycin A, structure 1, is depicted). The product of phosphorylation, in this case phospho-kanamycin A (structure 2), is devoid of antibacterial activity.

(Eq. 2)

(Eq. 3)

where N₂ is the number of bacteria at time t₂, N₁ is the number of bacteria at time t₁, n is the number of doublings, and g is the doubling time.

Pairwise Competition Experiments—Growth cultures of each strain (E. coli K-12, E. coli JM83, or E. coli DH10B) harboring either the aph(3')-Ia or the bla_TEM-1 genes with the high or low copy plasmids were diluted and mixed to 1:1 ratio to 10⁵ cells/ml. Cells were grown with shaking (180 rpm) for 24 h in either LB broth or glucose minimal medium without antibiotics. When E. coli JM83 and E. coli DH10B were grown in the glucose minimal medium, the medium was supplemented with proline or leucine, respectively. The number of cells carrying either the aph(3')-Ia or the bla_TEM-1 genes was counted on LB agar plate containing kanamycin or ampicillin, respectively.

Bacterial Growth Curves—Overnight cultures (30 µl) of E. coli strains (E. coli K-12, E. coli JM83, and E. coli DH10B) harboring the aph(3')-Ia or the bla_TEM-1 gene were inoculated separately into 3 ml of LB broth containing kanamycin or ampicillin, respectively. Cells were grown for 2 h at 37 °C and then diluted to reach an A₆₀₀ of 0.1. Cell cultures were further diluted 1000-fold and were grown with shaking (180 rpm) at 37 °C in the glucose minimal medium without antibiotics. The medium was supplemented with proline and leucine for E. coli JM83 and E. coli DH10B, respectively. The absorbance of the cultures was measured at 600 nm at various time intervals.

Plasmid Loss Analysis—Overnight cultures of E. coli K-12 strains harboring the aph(3')-Ia or the bla_TEM-1 genes on the low or high copy plasmids were diluted 1000-fold and grown in LB medium in the absence of antibiotics with agitation (180 rpm) at 37 °C. Every 12 h, the cultures were diluted 100-fold in fresh LB broth. Every 5 days cultures were diluted 10⁵-10⁷-fold and plated on LB agar plates without antibiotics. Then, one hundred colonies from each culture were transferred onto LB agar plates containing kanamycin or ampicillin, and the newly formed colonies that retained plasmids were counted.

Another plasmid loss test with E. coli K-12 harboring either plasmid pACYC177 or pACYCD216W was performed as described above. Cultures were plated on LB agar plates not containing antibiotics every 4 days, and the colonies harboring plasmids were selected with ampicillin for both pACYC177 and pACYCD216W. All the experiments for plasmid-loss were performed three times.

	RESULTS AND DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

 
The work commenced with in vitro investigations with purified APH(3')-Ia and APH(3')-IIa, both of which have been purified to homogeneity in our laboratory (20). Quench-flow experiments for the evaluation of microscopic rate constants were carried out with [-³²P]ATP, as described earlier (20). The results of a representative pre-steady-state experiment for the two activities of APH(3')-Ia, phosphoryl transfer to kanamycin A and to water, are given in Fig. 2. The reactions consisted of two phases, a burst phase and a steady-state phase in both cases as shown in Fig. 2.

View larger version (12K): [in this window] [in a new window]   FIGURE 2. Pre-steady-state kinetics of APH(3')-Ia catalyzed reaction. A, phosphate is transferred to kanamycin A. The reaction mixture contained 100 mM PIPES (pH 7.0), 10 µM APH(3')-Ia, 300 µM ATP, including a trace of [-32P]ATP, 100 µM kanamycin A, and 10 mM MgCl2. B, water molecule is phosphate acceptor (ATPase activity of APH(3')-Ia). The reaction mixture did not contain aminoglycoside.

View larger version (16K): [in this window] [in a new window]   FIGURE 3. Determination of the in vivo concentrations of APH(3')-Ia in E. coli K-12. C, E. coli K-12 strain without any plasmid (negative control); 1, E. coli K-12 strain harboring the low copy plasmid pACYC-APH; 2, E. coli K-12 strain carrying the high copy plasmid pUC-APH; M, the purified APH(3')-Ia as external standards (0.6, 1.2, 3.1, 6.2, and 12.5 µg). The arrow indicates APH(3')-Ia protein.

We have used both high (pUC19, > 200 copies per cell) and low copy (pACYC177, 10–12 copies per cell) plasmids (21). The plasmids were elaborated to possess the aph(3')-Ia gene (pUC-APH and pACYC-APH) or the bla_TEM-1 gene (for the TEM-1 -lactamase; a resistance enzyme for -lactam antibiotics; pUC-TEM and pACYC-TEM) as a control, each under the aph(3')-Ia promoter sequence. The two genes are essentially the same size (816 bp and 792 bp for the aph(3')-Ia and bla_TEM-1 genes, respectively). The four constructed plasmids were introduced by transformation into the antibiotic susceptible strain E. coli K-12 and into its two laboratory derivatives, E. coli JM83 and E. coli DH10B. The presence of various chromosomal mutations in the two laboratory strains results in their lower growth rates (E. coli DH10B has the lowest rate, as discussed later) in comparison to the parental E. coli K-12 strain. One might expect that the extra burden imposed by production of resistance enzymes (and the attendant ATPase reaction of APH(3')s) would produce a more profound effect on strains that are already attenuated in their growth rates. The low and high copy plasmids were expected to produce concentrations of APH(3')-Ia within the range for expression of the enzyme by clinical strains in vivo (22). We determined the in vivo concentrations of APH(3')-Ia by a slight modification of a known methodology (23). Bacteria not harboring the plasmid and purified APH(3')-Ia were used as a negative control and as an external standard, respectively (Fig. 3). Concentrations of APH(3')-Ia in vivo were evaluated at 50 ± 10 µM and 480 ± 80 µM for the E. coli K-12 strains harboring the low and the high copy plasmids, respectively. These concentrations are not atypical for an important enzyme in bacteria (24, 25).

The doubling times (e.g. generation times) for E. coli K-12 harboring low and high copy plasmids were 29 and 35 min, respectively. Doubling times were the same whether the plasmids contained the aph(3')-Ia or the bla_TEM-1 genes, hence no measurable effect on growth was attributable to the ATPase activity of APH(3')-Ia. The amounts of ATP hydrolyzed by APH(3')-Ia in the absence of an aminoglycoside in E. coli harboring pACYC-APH and pUC-APH during a single doubling time were evaluated to be 1.8 ± 0.5 mM and 20.1 ± 3.0 mM, respectively (from concentration of APH(3')-Ia in vivox slowest rate constant (k_cat) x doubling time). The effect on the ATPase activity is 3-fold or larger in the presence of aminoglycosides (Tables 1 and 2). Like for many other critical metabolites, concentrations of ATP in bacteria have been evaluated at high values of 3–5 mM (26–30). These determinations indicate that the mere adventitious hydrolysis of ATP by the constitutively expressed APH(3')-Ia has the potential of consuming as much as severalfold of the existing pool of ATP during a single bacterial doubling time. Clearly, bacteria absorb much of this cost in the loss of ATP, largely because of the ability of ATP to be regenerated by the metabolic process. However, we assumed that the cost could not be inconsequential.

View larger version (14K): [in this window] [in a new window]   FIGURE 4. Growth curves of E. coli strains harboring the aph(3')-Ia or the blaTEM-1 gene in the glucose minimal medium not containing antibiotics. A, E. coli K-12 strains harboring plasmid pACYC-APH (), pACYC-TEM (•), pUC-APH (), and pUC-TEM (). B, E. coli JM83 strains carrying plasmid pACYC-APH (), pACYC-TEM (•), pUC-APH (), and pUC-TEM (). C, E. coli DH10B strains containing plasmid pACYC-APH (), pACYC-TEM (•), pUC-APH (), and pUC-TEM ().

Subsequently, the potential cost of the ATPase activity of APH(3')-Ia was measured by pairwise competition experiments. Mixtures (1:1) of strains carrying aph(3')-Ia gene and bla_TEM-1 gene were incubated for 24 h in both LB broth and the glucose minimal medium, followed by selective plating on kanamycin- and ampicillin-containing agar for counting of the cells. There was no significant difference (Table 3).

We could not estimate the effect of ATPase activity of APH(3')-Ia on the plasmid maintenance with E. coli K-12 strains harboring pUC-APH and pUC-TEM, because both strains completely lost their plasmids within 100 generations of growth, indicative of the high cost of high copy plasmid maintenance. Significantly, E. coli K-12 strain harboring the low copy pACYC-APH lost its plasmid more rapidly than that containing pACYC-TEM. The former lost 50% of the plasmids in 1500 generations in contrast to 10% loss from the latter strain (Table 4). It is important to restate that plasmids and promoters are identical in both cases and the only difference is the nature of the resistance genes, which are of the same size.

View larger version (15K): [in this window] [in a new window]   FIGURE 5. Loss of plasmid DNA within generations of bacterial growth. E. coli K-12 strain harboring plasmid pACYC177 (•), which contains the genes for both the wild-type APH(3')-Ia and TEM-1, lost the plasmid more rapidly than the strain harboring plasmid pACYC-APH (), which encoded only the wild-type aph(3')-Ia gene. The E. coli K-12 strain containing plasmid pACYCD216W (), which contains the gene for the mutant APH(3')-Ia and TEM-1 also expelled plasmids more rapidly than that harboring plasmid pACYC-TEM (), which produced TEM-1.

	FOOTNOTES

 
^* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ To whom correspondence should be addressed: Dept. of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556. Tel.: 574-631-2933; Fax: 574-631-6652; E-mail: mobashery{at}nd.edu.

² The abbreviations used are: APH(3'), aminoglycoside 3'-phosphotransferase; PIPES, 1,4-piperazinediethanesulfonic acid; LB, Luria-Bertani broth.

³ redpoll.pharmacy.ualberta.ca/CCDB.

⁴ www2.uta.edu/vanwaasbergen2/micro/growth.html.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS AND DISCUSSION REFERENCES

 

1. Wright, G. D., Berghuis, A. M., and Mobashery, S. (1998) Adv. Exp. Med. Biol. 456, 27–69[Medline] [Order article via Infotrieve]
2. Wright, G. D. (1999) Curr. Opin. Microbiol. 2, 499–503[CrossRef][Medline] [Order article via Infotrieve]
3. Vakulenko, S. B., and Mobashery S. (2003) Clin. Microbiol. Rev. 16, 430–450[Abstract/Free Full Text]
4. Magnet, S., and Blanchard, J. S. (2005) Chem. Rev. 105, 477–497[CrossRef][Medline] [Order article via Infotrieve]
5. Kim, C., and Mobashery, S. (2005) Bioorg. Chem. 33, 149–158[CrossRef][Medline] [Order article via Infotrieve]
6. Gillespie, S. H., and McHugh, T. D. (1997) Trends Microbiol. 5, 337–339[CrossRef][Medline] [Order article via Infotrieve]
7. Lenski, R. E. (1997) Antibiotic Resistance: Origins, Evolution, Selection, and Spread, pp. 131–151, Wiley, Chichester, NY
8. Schrag, S., Perrot, V., and Levin B. R. (1997) Proc. R. Soc. London 264, 1287–1291[Medline] [Order article via Infotrieve]
9. Salyers, A. A., and Amábile-Cuevas, C. F. (1997) Antimicrob. Agents Chemother. 41, 2321–2325[Medline] [Order article via Infotrieve]
10. Andersson, D. I., and Levin, B. R. (1999) Curr. Opin. Microbiol. 2, 489–493[CrossRef][Medline] [Order article via Infotrieve]
11. Andersson, D. I. (2003) Curr. Opin. Microbiol. 6, 452–456[CrossRef][Medline] [Order article via Infotrieve]
12. Siregar, J. J., Lerner, S. A., and Mobashery, S. (1994) Antimicrob. Agents Chemother. 38, 641–647[Abstract/Free Full Text]
13. Siregar, J. J., Miroshnikov, K., and Mobashery, S. (1995) Biochemistry 34, 12681–12688[CrossRef][Medline] [Order article via Infotrieve]
14. Smith, M. A., and Bidochka, M. J. (1998) Can. J. Microbiol. 44, 351–355[CrossRef][Medline] [Order article via Infotrieve]
15. Goodsell, D. S. (1991) Trends Biochem. Sci. 16, 203–206[CrossRef][Medline] [Order article via Infotrieve]
16. Nanninga, N. (1985) Molecular Cytology of Escherichia coli, pp. 161–197, Academic Press, London, UK
17. Guihard, G., Bénédetti, H., Besnard, M., and Letellier, L. (1993) J. Biol. Chem. 268, 17775–17780[Abstract/Free Full Text]
18. Bagel, S., Hüllen, V., Weidemann, B., and Heisig, P. (1999) Antimicrob. Agents Chemother. 43, 868–875[Abstract/Free Full Text]
19. Becker, E. C., and Meyer, R. J. (1997) J. Bacteriol. 179, 5947–5950[Abstract/Free Full Text]
20. Kim, C., Haddad, J., Vakulenko, S. B., Meroueh, S. O., Wu, Y., Yan, H., and Mobashery, S. (2004) Biochemistry 43, 2373–2383[Medline] [Order article via Infotrieve]
21. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., pp. 1.3–1.6, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
22. Reisbig, M. D., Hossain, A., and Hanson, N. D. (2003) J. Antimicrob. Chemother. 51, 1141–1151[Abstract/Free Full Text]
23. Golemi, D., Maveyraud, L., Vakulenko, S., Samama, J.-P., and Mobashery, S. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 14280–14285[Abstract/Free Full Text]
24. Louie, T. M., Xie, X. S., and Xun, L. (2003) Biochemistry 42, 7509–7517[CrossRef][Medline] [Order article via Infotrieve]
25. Seyer, K., Lessard, M., Piette, G., Lacroix, M., and Saucier, L. (2003) Appl. Environ. Microbiol. 69, 3231–3237[Abstract/Free Full Text]
26. Diez-Gonzalez, F., and Russell, J. B. (1997) FEMS Microbiol. Lett. 151, 71–76[CrossRef][Medline] [Order article via Infotrieve]
27. Goss, S. R., Spice, A. B., and Nichols, W. W. (1988) FEBS Lett. 228, 245–248[Medline] [Order article via Infotrieve]
28. Lasko, D. R., and Wang, D. I. C. (1996) Biotechnol. Bioeng. 52, 364–372[CrossRef]
29. Rohwer, J. M., Jensen, P. R., Shinohara, Y., Postma, P. W., and Westerhoff, H. V. (1996) Eur. J. Biochem. 235, 225–230[Medline] [Order article via Infotrieve]
30. Rozkov, A., and Enfors, S. -O. (1999) Biotechnol. Bioeng. 62, 730–738[Medline] [Order article via Infotrieve]

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				M. Suvorov, S. B. Vakulenko, and S. Mobashery Cytoplasmic-Membrane Anchoring of a Class A {beta}-Lactamase and Its Capacity in Manifesting Antibiotic Resistance Antimicrob. Agents Chemother., August 1, 2007; 51(8): 2937 - 2942. [Abstract] [Full Text] [PDF]

				M. Hainrichson, O. Yaniv, M. Cherniavsky, I. Nudelman, D. Shallom-Shezifi, S. Yaron, and T. Baasov Overexpression and Initial Characterization of the Chromosomal Aminoglycoside 3'-O-Phosphotransferase APH(3')-IIb from Pseudomonas aeruginosa Antimicrob. Agents Chemother., February 1, 2007; 51(2): 774 - 776. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 281/11/6964    most recent M513257200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, C. Articles by Mobashery, S. Search for Related Content PubMed PubMed Citation Articles by Kim, C. Articles by Mobashery, S. Social Bookmarking                      What's this?